Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01667978 · ClinicalTrials.gov registry record · NA
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01667978 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 35 participants.
The verdict
NCT01667978, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if women taking the atazanavir and ritonavir have lower levels of a birth control medication called norethindrone. Norethindrone (also called the mini pill) is an FDA (Food and Drug Administration) approved progestin-only birth control pill used to prevent pregnancy. Norethindrone is the standard medication used in women who take the progestin only pill to prevent pregnancy. There are other birth control pills which contain different medications. The investigators want to learn if HIV medications (atazanavir and ritonavir) make the blood level of this birth control pill higher or lower. If the levels of norethindrone are too low it may not work to prevent pregnancy. The investigators also hope to learn about changes in the vaginal fluids and cervical fluids when women are taking this birth control pill.
Interventions
- DRUG Norethindrone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01667978
The ClinicalTrials.gov registry entry for NCT01667978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Norethindrone acetate is the first listed.
NCT01667978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01667978 about?
NCT01667978 is a clinical study titled "The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception". The purpose of this study is to learn if women taking the atazanavir and ritonavir have lower levels of a birth control medication called norethindrone. Norethindrone (also called the mini pill) is an FDA (Food and Drug Administration) approved progestin-only birth control pill used to prevent pregn...
What is the current status of trial NCT01667978?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01667978?
The interventions under investigation include: Norethindrone acetate (DRUG).
Who is sponsoring clinical trial NCT01667978?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.